ABOUT

CEO GREETING


THANK YOU FOR

TRUST US 

We would like to express our sincere gratitude to all our customers who have trusted and visited CNS Pharm Korea Co., Ltd.

KOREA CNS PHARM

CEO MESSAGE 



THANK YOU FOR TRUST US

We sincerely thank all our clients

who have trusted and supported CNS Pharm Korea Co., Ltd.

Founded in 2002, CNS Pharm Korea Co., Ltd. is a professional OEM and ODM company that plans, researches, and develops health functional foods that satisfy the market, customers, and consumers through the latest equipment and strict quality control.


In order to observe the rapidly changing health functional food market and consumers' interest in health with a sensitive and careful eye and produce products that meet these trends, we do not spare any investment in improving and developing research and development and quality control every year. In addition, we are a company that places quality management at the top of its business capabilities more than any other task, and all executives and employees strive to have differentiated capabilities as products that can be consumed safely and as a trustworthy company. Through these efforts, we are forming a trusted partnership by supplying high-quality products to leading domestic companies as well as overseas partners, and laying the foundation for responding to a wider variety of formulations and higher production volume through expansion of the production headquarters in 2023. In addition, we have successfully developed and produced our own individually approved raw material, LD100®, and by discovering and strengthening various individually approved raw material pipelines, we aim to become a global-level R&D manufacturing company beyond a simple OEM/ODM company.


CNS Pharm Korea Co., Ltd. promises to be a trusted partner to all customers with the best quality, latest trends, production diversity and creativity.

Chairman of CNS Pharm Korea Co., Ltd.

Gong Jeong Oh

KOREA CNS PHARM

CEO MESSAGE


CNS Pharm Korea Co., Ltd., founded in 2022, is an OEM and ODM company which plans, researches, and develops health functional food that satisfy the market, customers, and consumers through the latest equipment and rigorous quality control.

In order to observe the rapidly changing health functional food market and consumers' interest in health from a sensitive and attentive perspective and to produce products that are in line with this, we spare no effort to improve and develop R&D and quality management every year. In addition, all employees are committed to putting quality management at the top of our business capabilities above all other issues, and to develop differentiated capabilities as a company that can be trusted with products that can be consumed with peace of mind.

Through these efforts, we are supplying quality products to leading domestic companies as well as overseas partners and forming trusted partnerships and we have laid the foundation to respond to more diverse formulations and higher production volumes with the expansion of our production headquarters in 2023.

In addition, we have successfully developed and produced LD100®, our own proprietary ingredient subject to individual recognition ingredient and we aim to become a global-level R&D and manufacturing company, not just an OEM/ODM company, by discovering and strengthening a pipeline of various proprietary ingredients.


CNS Pharm Korea Co., Ltd. promises to be a trusted partner to all customers with the best quality, latest trends, diversity and creativity in production.

Chairman of CNS Pharm Korea Co., Ltd.

Gong Jeong Oh


CNSPHARM THE BEST PARTNER FOR

YOUR SUCCESSFUL BUSINESS



CNSPHARM THE BEST PARTNER FOR YOUR SUCCESSFUL BUSINESS


CNS Pharm Korea Co.,Ltd.


Headquarters

  Address : 1st floor, Sangnok Bldg, 19 Yanghwa-ro 10-gil, Mapo-gu, Seoul, Republic of Korea 

Phone : +82-2-3143-0027 

  Fax : +82-2-3143-0384 


Factory 

Address : 16 Sanggyeong-ro, Wonnam-myeon, Eumseong-gun, Chungcheongbuk-do, Korea 

Phone : +82-43-873-2102 

Fax : +82-43-873-2104 


Copyright © CNS Pharm Korea Co.,Ltd. 2024.